Histaminergic regulation of natural killer cell-mediated clearance of tumour cells in mice

Scandinavian Journal of Immunology

Volumn 43, Issue 1, 1996, Pages 9-15

  Asea, A ^a   Hermodsson, S ^a   Hellstrand, K ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AH 20239AA; ALPHA INTERFERON; HISTAMINE; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; INTERLEUKIN 2; RANITIDINE; RECOMBINANT ALPHA INTERFERON; RECOMBINANT INTERLEUKIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL DESTRUCTION; CONTROLLED STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; LYMPHOMA CELL; MASTOCYTOMA; MELANOMA CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0030027630     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-14.x     Document Type: Article

References (30)

1. Plaut M, Lichtenstein LM. Histamine and immune responses. In: Ganéllin CR, Parson ME, eds. Pharmacology of Histamine Receptors. Bristol: John Wright & Sons, 1982:392-435.
2. Kahlson G, Rosengren E, Biogenesis and Physiology of Histamine. London: Edward Arnold Ltd, 1971.
3. 2-receptor-mediated regulation of human natural killer cell activity. J Immunol 1986;137:656-60.
4. Hellstrand K, Hermodsson S. Synergistic activity of human natural killer cells by histamine and interleukin-2. Int Arch Allergy Appl Immunol 1990;92:379-89.
5. Hellstrand K, Kylefjord H, Asea A, Hermodsson S. Regulation of natural killer cell response to interferon-α by biogenic amines. J Interferon Res 1992;12:199-206.
6. Hellstrand K, Asea A, Dahlgren C, Hermodsson S. Histaminergic regulation of natural killer cells: Role of reactive oxygen metabolites. J Immunol 1994;153:4940-7.
7. Nair MPN, Schwartz SA. Effects of histamine and histamine antagonists on natural and antibody-dependent cellular cytotoxicity of human lymphocytes in vitro. Cell Immunol 1983;81:45-60.
8. Nair MPN, Cilik JM, Schwartz SA. Histamine-induced suppressor factor inhibition of NK cells: Reversal with interferon and interleukin-2. J Immunol 1986;136:2456-62.
9. Carlsson R, Dohlsten M, Sjögren HO. Histamine modulates the production of interferon-gamma and interleukin-2 by human monunuclear cells. Cell Immunol 1986;95:104-12.
10. Dohlsten M, Sjögren HO, Carlsson R. Histamine inhibits interferon-gamma production via suppression of interleukin-2 synthesis. Cell Immunol 1986;101:493-501.
11. Dohlsten M, Sjögren HO, Carlsson R. Histamine acts directly on human T-cells to inhibit interleukin-2 and interferon-gamma induction. Cell Immunol 1987;109:65-74.
12. Hellstrand K, Asea A, Hermodsson S. Role of histamine in natural killer cell-mediated resistance under tumor cells. J Immunol 1990;145:4365-70.
13. Hellstrand K, Asea A, Hermodsson S. Role of histamine in natural killer-cell-dependent protection against herpes simplex virus type 2 infection in mice. Clin Diagn Lab Immunol 1995;2:3-6.
14. Hanna N. The role of natural killer cells in the control of tumor growth and metastasis. Biochim Biophys Acta 1985;780:213-226.
15. Huddlestone JR, Merigan TC, Oldstone M. Induction and kinetics of natural killer cells in humans following interferon therapy. Nature 1979;282:417-19.
16. Saxena RK, Saxena QB, Alder WH. Mechanism of loss of natural killer activity in P815 ascites tumor bearing DBA/2 mice. Nat Immun Cell Growth Regul 1983;3:34-42.
17. Hellstrand K, Asea A, Hermodsson S. Histaminergic regulation of antibody-dependent cellular cytotoxicity of granulocytes, monocytes and natural killer cells. J Leukoc Biol 1994;55:392-7.
18. Freston JW. Omaprazole, hypergastrinemia, and gastric carcinoid tumors. Ann Intern Med 1994;121:232-3.
19. Nordlund JJ, Askenase PW. The effect of histamine, antihistamine, and mast cell stabilizer on the growth of Cloudman melanoma in DBA/2 mice. J Invest Dermatol 1983;81:28-31.
20. Burtin C, Scheinman P, Salomon JC. Lespinats G, Loisillier F, Canu P. The influence of intraperitoneal injections of histamine on tumor growth in fibrosarcoma-bearing mice. Cancer Lett 1981;12:195-201.
21. 2 receptors. Br J Cancer 1982;45:54-60.
22. Fray A, Burtin C, Scheinman P, Salomon JC, Lespinats G, Canu P. In vivo and in vitro antitumor activity of dimaprit. Agents Actions 1985;16:284-6.
23. Osband ME, Hamilton D, Shen Y et al. Successful tumor immunotherapy with cimetidine in mice. Lancet 1981;1:636-8.
24. Flodgren P, Borgström T, Jönsson P-E, Lindström C, Sjögren HO. Metastatic malignant melanoma: Regression induced by combined treatment with interferon (HuIFN-a/Le/) and cimetidine. Int J Cancer 1983;32:657-65.
25. Hanna N. In vivo activities of NK cells against primary and metastatic tumors in experimental animals. In: Immunobiology of Natural Killer Cells. CRC Press II, 1985;1-10.
26. Nielsen HJ, Nielsen H, Moesgaard F et al. The effect of ranitidine on cellular immunity in patients with multiple myeloma. Cancer Immunol Immunother 1990;32:201-5.
27. Beaven MA. Factors regulating availability of histamine at tissue receptors. In: Ganéllin CR, Parsons ME, eds. Pharmacology of Histamine Receptors. Britsol: John Wright & Sons, 1982: 103-45.
28. Burtin C, Noirot C, Paupe J, Scheinmann P. Decreased blood histamine levels in patients with solid malignant tumours. Br J Cancer 1983;47:367-72.
29. Hellstrand K, Naredi P, Lindnér P et al. Histamine in immunotherapy of advanced melanoma: A pilot study. Cancer Immunol Immunother 1994;39:416-19.
30. Brune B, Hellstrand K. Histamine and interleukin-2 in high-risk acute myelogenous leukemia. Br J Haematol; in press.